P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
P11712 |
CP2C9_HUMAN |
Bacterial infection [ICD-11: 1A00-1C4Z] |
Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P16473 |
TSHR_HUMAN |
Hypo-thyroidism [ICD-11: 5A00] |
P16473 |
TSHR_HUMAN |
Thyroid cancer [ICD-11: 2D10] |